Intermittent chemotherapy in metastatic androgen-independent prostate cancer.
Medical Oncology Service. Hospital del Mar - IMAS, Experimental Cancer Therapeutics Unit (URTEC) IMIM-H del Mar, Barcelona, Spain. jbellmunt@imas.imim.es
Joaquim
J
Bellmunt
Santiago
S
Albiol
Joan
J
Albanell
D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage*; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D011788:Quality of Life; D016019:Survival Analysis
D018931:Antineoplastic Agents, Hormonal